@ADAlthousePhD Here is one highly doubtful example https://t.co/qH4LwSdwxr
@drjohnm @adamcifu Agree, but no HFpEF treatment improves mortality Overall, "real-world" PA monitor reduces cost. An imp. outcome too? https://t.co/JaSkwGWRY0
RT @JACCJournals: Real world experience w/ implantable PAP sensor shows reduction in heart failure hospitalization & costs #JACC https://t.…
This is a good example of success with therapy outside the strict clinical trial setting. https://t.co/3hb9RfmodG
Ambulatory Hemodynamic Monitoring Reduces Heart Failure Hospitalizations in “Real-World” Clinical Prac https://t.co/Hn1sYHUz3b @CardioIAN
RT @JACCJournals: Real world experience w/ implantable PAP sensor shows reduction in heart failure hospitalization & costs #JACC https://t.…
RT @JACCJournals: Does use of ambulatory hemodynamic monitoring in heart failure pts improve outcomes? Analysis of 1K pts in #JACC https://…
RT @JACCJournals: Does use of ambulatory hemodynamic monitoring in heart failure pts improve outcomes? Analysis of 1K pts in #JACC https://…
RT @JACCJournals: Does use of ambulatory hemodynamic monitoring in heart failure pts improve outcomes? Analysis of 1K pts in #JACC https://…
RT @JACCJournals: Real world experience w/ implantable PAP sensor shows reduction in heart failure hospitalization & costs #JACC https://t.…
RT @JACCJournals: Does use of ambulatory hemodynamic monitoring in heart failure pts improve outcomes? Analysis of 1K pts in #JACC https://…
RT @JACCJournals: Does use of ambulatory hemodynamic monitoring in heart failure pts improve outcomes? Analysis of 1K pts in #JACC https://…
Does use of ambulatory hemodynamic monitoring in heart failure pts improve outcomes? Analysis of 1K pts in #JACC https://t.co/mOEufi1Vwt https://t.co/bYzu0QGhaX
RT @JACCJournals: Real world experience w/ implantable PAP sensor shows reduction in heart failure hospitalization & costs #JACC https://t.…
Real world experience w/ implantable PAP sensor shows reduction in heart failure hospitalization & costs #JACC https://t.co/dEWKQzpsSK https://t.co/hdA9mPgnzS
RT @JACCJournals: At 6 months of follow-up, 45% lower rate of cumulative HF hospitalizations seen after PAP sensor implant #JACC https://t.…
RT @JACCJournals: At 6 months of follow-up, 45% lower rate of cumulative HF hospitalizations seen after PAP sensor implant #JACC https://t.…
RT @JACCJournals: At 6 months of follow-up, 45% lower rate of cumulative HF hospitalizations seen after PAP sensor implant #JACC https://t.…
RT @JACCJournals: At 6 months of follow-up, 45% lower rate of cumulative HF hospitalizations seen after PAP sensor implant #JACC https://t.…
RT @JACCJournals: At 6 months of follow-up, 45% lower rate of cumulative HF hospitalizations seen after PAP sensor implant #JACC https://t.…
RT @JACCJournals: At 6 months of follow-up, 45% lower rate of cumulative HF hospitalizations seen after PAP sensor implant #JACC https://t.…
RT @JACCJournals: At 6 months of follow-up, 45% lower rate of cumulative HF hospitalizations seen after PAP sensor implant #JACC https://t.…
RT @JACCJournals: At 6 months of follow-up, 45% lower rate of cumulative HF hospitalizations seen after PAP sensor implant #JACC https://t.…
At 6 months of follow-up, 45% lower rate of cumulative HF hospitalizations seen after PAP sensor implant #JACC https://t.co/lwHlJOKI2e https://t.co/bjh5aEcvwS
https://t.co/ehaeQAMLjc https://t.co/4AQFFGKyJr important data, need to inc use of #Cardiomems @JACCJournals @CircAHA @drjohnm
Reduction in Heart Failure Hospitalizations With CardioMems Maintained in the 'Real World' https://t.co/MyccAOA6Km https://t.co/lZQwBSZDN9
Reduction in Heart Failure Hospitalizations With Ambulatory Hemodynamic Monitoring Seen in Clinical Trials Is… https://t.co/cmzy4vTizG